Machine learning-based construction of Immunogenic cell death-related score for improving prognosis and personalized treatment in glioma
Abstract Immunogenic cell death (ICD) is capable of activating both innate and adaptive immune responses. In this study, we aimed to develop an ICD-related signature in glioma patients and facilitate the assessment of their prognosis and drug sensitivity. Consensus clustering and non-negative matrix...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-15658-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849226337174159360 |
|---|---|
| author | Guoyin Li Yukui Zhao Yubo He Zhaoqiang Qian Yiwen Liu Xiaoyan Li Lili Li Zhiqiang Liu |
| author_facet | Guoyin Li Yukui Zhao Yubo He Zhaoqiang Qian Yiwen Liu Xiaoyan Li Lili Li Zhiqiang Liu |
| author_sort | Guoyin Li |
| collection | DOAJ |
| description | Abstract Immunogenic cell death (ICD) is capable of activating both innate and adaptive immune responses. In this study, we aimed to develop an ICD-related signature in glioma patients and facilitate the assessment of their prognosis and drug sensitivity. Consensus clustering and non-negative matrix factorization (NMF) were performed to classify patients into subgroups. A least absolute shrinkage and selection operator (LASSO) logistic regression model was constructed to establish an ICD-related risk score (ICDS). CIBERSORT and ESTIMATE algorithms were employed to evaluate the infiltration of immune cells. Flow cytometry, CCK-8, EdU, and Transwell assays were used to detect cell proliferation and migration abilities. qPCR, Western blotting, immunohistochemistry and immunofluorescence were utilized to detect mRNA and protein expression levels. The ICDS proved effective in predicting the prognosis of glioma patients in both the training and two validating cohorts. The ICDS exhibited significant advantages when compared to the 71 previously published signatures. Patients with a high ICDS score demonstrated marked enhancement in immune cell infiltration and expression of immune checkpoint inhibitor-related genes. Furthermore, SERPINH1, one of the 14 key genes used to establish the ICDS, was abnormally overexpressed in gliomas and activate JAK/STAT signaling, thereby promoting glioma cell proliferation and migration. We developed an ICDS marker to evaluate the prognosis and drug response of glioma patients, and confirmed that SERPINH1 promotes the malignant phenotype of gliomas by modulating the JAK/STAT signaling pathway. |
| format | Article |
| id | doaj-art-2c65653aaa414b37a9a22fd144767fef |
| institution | Kabale University |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-2c65653aaa414b37a9a22fd144767fef2025-08-24T11:24:07ZengNature PortfolioScientific Reports2045-23222025-08-0115111710.1038/s41598-025-15658-6Machine learning-based construction of Immunogenic cell death-related score for improving prognosis and personalized treatment in gliomaGuoyin Li0Yukui Zhao1Yubo He2Zhaoqiang Qian3Yiwen Liu4Xiaoyan Li5Lili Li6Zhiqiang Liu7Key Laboratory of Modern Teaching Technology, Ministry of Education, Shaanxi Normal UniversityKey Laboratory of Modern Teaching Technology, Ministry of Education, Shaanxi Normal UniversityDepartment of Neurosurgery, Shanxi Provincial People’s HospitalCollege of Life Sciences, Shaanxi Normal UniversityKey Laboratory of Modern Teaching Technology, Ministry of Education, Shaanxi Normal UniversityDepartment of Blood Transfusion, Heping Branch, Shanxi Provincial People’s HospitalCollege of Life Science and Agronomy, Zhoukou Normal UniversityKey Laboratory of Modern Teaching Technology, Ministry of Education, Shaanxi Normal UniversityAbstract Immunogenic cell death (ICD) is capable of activating both innate and adaptive immune responses. In this study, we aimed to develop an ICD-related signature in glioma patients and facilitate the assessment of their prognosis and drug sensitivity. Consensus clustering and non-negative matrix factorization (NMF) were performed to classify patients into subgroups. A least absolute shrinkage and selection operator (LASSO) logistic regression model was constructed to establish an ICD-related risk score (ICDS). CIBERSORT and ESTIMATE algorithms were employed to evaluate the infiltration of immune cells. Flow cytometry, CCK-8, EdU, and Transwell assays were used to detect cell proliferation and migration abilities. qPCR, Western blotting, immunohistochemistry and immunofluorescence were utilized to detect mRNA and protein expression levels. The ICDS proved effective in predicting the prognosis of glioma patients in both the training and two validating cohorts. The ICDS exhibited significant advantages when compared to the 71 previously published signatures. Patients with a high ICDS score demonstrated marked enhancement in immune cell infiltration and expression of immune checkpoint inhibitor-related genes. Furthermore, SERPINH1, one of the 14 key genes used to establish the ICDS, was abnormally overexpressed in gliomas and activate JAK/STAT signaling, thereby promoting glioma cell proliferation and migration. We developed an ICDS marker to evaluate the prognosis and drug response of glioma patients, and confirmed that SERPINH1 promotes the malignant phenotype of gliomas by modulating the JAK/STAT signaling pathway.https://doi.org/10.1038/s41598-025-15658-6GliomaImmunogenic cell deathPrognostic modelSERPINH1JAK/STAT pathway |
| spellingShingle | Guoyin Li Yukui Zhao Yubo He Zhaoqiang Qian Yiwen Liu Xiaoyan Li Lili Li Zhiqiang Liu Machine learning-based construction of Immunogenic cell death-related score for improving prognosis and personalized treatment in glioma Scientific Reports Glioma Immunogenic cell death Prognostic model SERPINH1 JAK/STAT pathway |
| title | Machine learning-based construction of Immunogenic cell death-related score for improving prognosis and personalized treatment in glioma |
| title_full | Machine learning-based construction of Immunogenic cell death-related score for improving prognosis and personalized treatment in glioma |
| title_fullStr | Machine learning-based construction of Immunogenic cell death-related score for improving prognosis and personalized treatment in glioma |
| title_full_unstemmed | Machine learning-based construction of Immunogenic cell death-related score for improving prognosis and personalized treatment in glioma |
| title_short | Machine learning-based construction of Immunogenic cell death-related score for improving prognosis and personalized treatment in glioma |
| title_sort | machine learning based construction of immunogenic cell death related score for improving prognosis and personalized treatment in glioma |
| topic | Glioma Immunogenic cell death Prognostic model SERPINH1 JAK/STAT pathway |
| url | https://doi.org/10.1038/s41598-025-15658-6 |
| work_keys_str_mv | AT guoyinli machinelearningbasedconstructionofimmunogeniccelldeathrelatedscoreforimprovingprognosisandpersonalizedtreatmentinglioma AT yukuizhao machinelearningbasedconstructionofimmunogeniccelldeathrelatedscoreforimprovingprognosisandpersonalizedtreatmentinglioma AT yubohe machinelearningbasedconstructionofimmunogeniccelldeathrelatedscoreforimprovingprognosisandpersonalizedtreatmentinglioma AT zhaoqiangqian machinelearningbasedconstructionofimmunogeniccelldeathrelatedscoreforimprovingprognosisandpersonalizedtreatmentinglioma AT yiwenliu machinelearningbasedconstructionofimmunogeniccelldeathrelatedscoreforimprovingprognosisandpersonalizedtreatmentinglioma AT xiaoyanli machinelearningbasedconstructionofimmunogeniccelldeathrelatedscoreforimprovingprognosisandpersonalizedtreatmentinglioma AT lilili machinelearningbasedconstructionofimmunogeniccelldeathrelatedscoreforimprovingprognosisandpersonalizedtreatmentinglioma AT zhiqiangliu machinelearningbasedconstructionofimmunogeniccelldeathrelatedscoreforimprovingprognosisandpersonalizedtreatmentinglioma |